PDP-DESONIDE DIN 02229323
Status: Marketed
Holder: PENDOPHARM DIVISION OF PHARMASCIENCE INC
Molecule: DESONIDE
Available to quote
Health Canada record
| Active ingredient(s) | DESONIDE 0.05 % |
|---|---|
| Dosage form | Ointment |
| Route | Topical |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | D07AB08 DESONIDE |
| Original market date | 14-Jan-1997 |
| Current status date | 06-Aug-2014 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DESONIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02229315 | PDP-DESONIDE | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Cream | DESONIDE 0.05 % | Marketed |
| 02516349 | PMS-DESONIDE | PHARMASCIENCE INC | Cream | DESONIDE 0.05 % | Approved |
| 02516357 | PMS-DESONIDE | PHARMASCIENCE INC | Ointment | DESONIDE 0.05 % | Approved |
| 02154862 | TRIDESILON 0.05% DESONIDE CREAM | PERRIGO INTERNATIONAL | Cream | DESONIDE 0.05 % | Cancelled Post Market |
| 02154870 | TRIDESILON 0.05% DESONIDE OINTMENT | PERRIGO INTERNATIONAL | Ointment | DESONIDE 0.05 % | Cancelled Post Market |
| 02348489 | VERDESO | GLAXOSMITHKLINE INC | Aerosol (Foam) | DESONIDE 0.05 % | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 15924 | 2014-08-05 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBERS |
| 2204 | 2001-10-09 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 4333 | 1996-08-22 | New Drug Submission (NDS) |
International API supply for DESONIDE
32 active FDA Drug Master Files.
Request a quote for PDP-DESONIDE